Cite
Jain A, Huang R, Lee J, et al. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. Can J Kidney Health Dis. 2021;8:20543581211057708doi: 10.1177/20543581211057708.
Jain, A., Huang, R., Lee, J., Jawa, N., Lim, Y. J., Guron, M., Abish, S., Boutros, P. C., Brudno, M., Carleton, B., Cuvelier, G. D. E., Gunaratnam, L., Ho, C., Adeli, K., Kuruvilla, S., Lajoie, G., Liu, G., Nathan, P. C., Rod Rassekh, S., Rieder, M., Waikar, S. S., Welch, S. A., Weir, M. A., Winquist, E., Wishart, D. S., Zorzi, A. P., Blydt-Hansen, T., Zappitelli, M., & Urquhart, B. (2021). A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. Canadian journal of kidney health and disease, 820543581211057708. https://doi.org/10.1177/20543581211057708
Jain, Anshika, et al. "A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol." Canadian journal of kidney health and disease vol. 8 (2021): 20543581211057708. doi: https://doi.org/10.1177/20543581211057708
Jain A, Huang R, Lee J, Jawa N, Lim YJ, Guron M, Abish S, Boutros PC, Brudno M, Carleton B, Cuvelier GDE, Gunaratnam L, Ho C, Adeli K, Kuruvilla S, Lajoie G, Liu G, Nathan PC, Rod Rassekh S, Rieder M, Waikar SS, Welch SA, Weir MA, Winquist E, Wishart DS, Zorzi AP, Blydt-Hansen T, Zappitelli M, Urquhart B. A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol. Can J Kidney Health Dis. 2021 Nov 17;8:20543581211057708. doi: 10.1177/20543581211057708. eCollection 2021. PMID: 34820133; PMCID: PMC8606978.
Copy
Download .nbib